These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 23649996

  • 1. A novel multi-unit tablet for treating circadian rhythm diseases.
    Liu Q, Gong Y, Shi Y, Jiang L, Zheng C, Ge L, Liu J, Zhu J.
    AAPS PharmSciTech; 2013 Jun; 14(2):861-9. PubMed ID: 23649996
    [Abstract] [Full Text] [Related]

  • 2. [Studies on preparation of isosorbide-5-mononitrate pulsatile controlled-release pellets and various influence factors].
    Wang R, Huang G, Fang Z.
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2008 Aug; 25(4):885-8. PubMed ID: 18788301
    [Abstract] [Full Text] [Related]

  • 3. Accelerating the dissolution of enteric coatings in the upper small intestine: evolution of a novel pH 5.6 bicarbonate buffer system to assess drug release.
    Varum FJ, Merchant HA, Goyanes A, Assi P, Zboranová V, Basit AW.
    Int J Pharm; 2014 Jul 01; 468(1-2):172-7. PubMed ID: 24727141
    [Abstract] [Full Text] [Related]

  • 4. Dual coating of swellable and rupturable polymers on glipizide loaded MCC pellets for pulsatile delivery: formulation design and in vitro evaluation.
    Yadav D, Survase S, Kumar N.
    Int J Pharm; 2011 Oct 31; 419(1-2):121-30. PubMed ID: 21807081
    [Abstract] [Full Text] [Related]

  • 5. Chitosan and enteric polymer based once daily sustained release tablets of aceclofenac: in vitro and in vivo studies.
    Mutalik S, Manoj K, Reddy MS, Kushtagi P, Usha AN, Anju P, Ranjith AK, Udupa N.
    AAPS PharmSciTech; 2008 Oct 31; 9(2):651-9. PubMed ID: 18500561
    [Abstract] [Full Text] [Related]

  • 6. Drug release and swelling kinetics of directly compressed glipizide sustained-release matrices: establishment of level A IVIVC.
    Sankalia JM, Sankalia MG, Mashru RC.
    J Control Release; 2008 Jul 02; 129(1):49-58. PubMed ID: 18456362
    [Abstract] [Full Text] [Related]

  • 7. Isosorbide-5-mononitrate (5-ISMN) sustained-release pellets prepared by double layer coating for reducing 5-ISMN migration and sublimation.
    Li G, Han D, Guan T, Zhao X, He H, Tang X.
    Int J Pharm; 2010 Nov 15; 400(1-2):138-44. PubMed ID: 20826202
    [Abstract] [Full Text] [Related]

  • 8. Release characteristics and in vitro-in vivo correlation of pulsatile pattern for a pulsatile drug delivery system activated by membrane rupture via osmotic pressure and swelling.
    Lin HL, Lin SY, Lin YK, Ho HO, Lo YW, Sheu MT.
    Eur J Pharm Biopharm; 2008 Sep 15; 70(1):289-301. PubMed ID: 18539015
    [Abstract] [Full Text] [Related]

  • 9. [Preparation and in vitro evaluation of tanshinone IIA pulsatile release pellets].
    Liang XD, Zheng Y, Fan TY.
    Beijing Da Xue Xue Bao Yi Xue Ban; 2010 Oct 18; 42(5):559-64. PubMed ID: 20957015
    [Abstract] [Full Text] [Related]

  • 10. Erodible time-dependent colon delivery systems with improved efficiency in delaying the onset of drug release.
    Del Curto MD, Palugan L, Foppoli A, Zema L, Gazzaniga A, Maroni A.
    J Pharm Sci; 2014 Nov 18; 103(11):3585-3593. PubMed ID: 25213173
    [Abstract] [Full Text] [Related]

  • 11. Controlled release of dual drug-loaded hydroxypropyl methylcellulose matrix tablet using drug-containing polymeric coatings.
    Lee BJ, Ryu SG, Cui JH.
    Int J Pharm; 1999 Oct 15; 188(1):71-80. PubMed ID: 10528084
    [Abstract] [Full Text] [Related]

  • 12. Sustained-release pellets prepared by combination of wax matrices and double-layer coatings for extremely water-soluble drugs.
    Tian L, Zhang Y, Tang X.
    Drug Dev Ind Pharm; 2008 Jun 15; 34(6):569-76. PubMed ID: 18568906
    [Abstract] [Full Text] [Related]

  • 13. Preparation and in vitro/in vivo evaluation of sustained-release venlafaxine hydrochloride pellets.
    Liu Y, Sun Y, Sun J, Zhao N, Sun M, He Z.
    Int J Pharm; 2012 Apr 15; 426(1-2):21-28. PubMed ID: 22266529
    [Abstract] [Full Text] [Related]

  • 14. Suitability of κ-carrageenan pellets for the formulation of multiparticulate tablets with modified release.
    Ghanam D, Kleinebudde P.
    Int J Pharm; 2011 May 16; 409(1-2):9-18. PubMed ID: 21335073
    [Abstract] [Full Text] [Related]

  • 15. Sustained release of acetaminophen from a heterogeneous mixture of two hydrophilic non-ionic cellulose ether polymers.
    Ebube NK, Jones AB.
    Int J Pharm; 2004 Mar 19; 272(1-2):19-27. PubMed ID: 15019065
    [Abstract] [Full Text] [Related]

  • 16. Drug release-modulating mechanism of hydrophilic hydroxypropylmethylcellulose matrix tablets: distribution of atoms and carrier and texture analysis.
    Park JB, Lim J, Kang CY, Lee BJ.
    Curr Drug Deliv; 2013 Dec 19; 10(6):732-41. PubMed ID: 23855499
    [Abstract] [Full Text] [Related]

  • 17. Controlled drug release from pellets containing water-insoluble drugs dissolved in a self-emulsifying system.
    Serratoni M, Newton M, Booth S, Clarke A.
    Eur J Pharm Biopharm; 2007 Jan 19; 65(1):94-8. PubMed ID: 17056237
    [Abstract] [Full Text] [Related]

  • 18. Development and release mechanism of diltiazem HCl prolonged release matrix tablets.
    Boyapally H, Nukala RK, Douroumis D.
    Drug Deliv; 2009 Feb 19; 16(2):67-74. PubMed ID: 19267297
    [Abstract] [Full Text] [Related]

  • 19. Design and evaluation of pH-independent pulsatile release pellets containing isosorbide-5-mononitrate.
    Liu Y, Liu S, Dai Q.
    Chem Pharm Bull (Tokyo); 2009 Jan 19; 57(1):55-60. PubMed ID: 19122316
    [Abstract] [Full Text] [Related]

  • 20. Floating elementary osmotic pump tablet (FEOPT) for controlled delivery of diethylcarbamazine citrate: a water-soluble drug.
    Khan ZA, Tripathi R, Mishra B.
    AAPS PharmSciTech; 2011 Dec 19; 12(4):1312-23. PubMed ID: 21969244
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.